HOME >> MEDICINE >> NEWS
Acrux patent portfolio advances in USA

  • New patent granted in USA for MDTS drug delivery system
  • Protection against copies of Acrux unique transdermal sprays extended out to 2022
  • Nine patents now granted in USA

Acrux has received notification of the grant of a US patent (number 6,978,945), which provides robust protection for its Metered Dose Transdermal Spray (MDTS)applicator for delivery of drugs. The applicator is currently used in the three women's health products that Acrux has under clinical development the contraceptive spray Nestorone MDTS, Testosterone MDTS to treat decreased libido and EvamistTM to treat menopause symptoms. EvamistTM is nearing completion of Phase 3 trials in the USA, with results expected to be available in the second quarter of 2006. The new patent does not expire until 31 July 2022, which is five years later than Acrux's other granted US patents.

Acrux CEO Igor Gonda commented "This new patent provides very broad protection for the familiar part of our products that the patient sees and uses. It means that copies of our unique transdermal spray devices that provide a precise and convenient means of drug delivery are now kept out of the market until 2022 at the earliest".

In addition, Acrux has been granted another US patent (number 6,998,138), expiring in 2017, which provides an additional layer of patent protection for delivery of anti-alopecia (baldness) drugs using Acrux's fast drying skin delivery technology. Alopecia treatments are a part of Acrux's valuable portfolio of dermatology products.


'"/>

Contact: Igor Gonda
61-383-790-100
Research Australia
1-Mar-2006


Page: 1

Related medicine news :

1. Acrux completes enrollment in key phase 2 trial
2. Acrux and Oreganon further expand their collaboration
3. Acrux granted first grant in Europe, triggering payment from Lilly
4. Acrux acquires rights to commercialise worlds first contraceptive spray
5. Four new us patents granted to Acrux for transdermal drug delivery
6. Acrux reports progress in development of Testosterone MD-Lotion(R) for men
7. Panbio files first patent application for Homogenous Assay Technology
8. GroPep awarded key patent for infertility treatment in Europe
9. Resonance Health Goup patent for diagnosis of liver fibrosis
10. VCR - US patent litigation update
11. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an update ... Puerto Rico , where the company manufactures ... Following a comprehensive onsite assessment, the ... temporary loss of power and minimal water damage due ... have resumed, and the company expects to return to ...
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
Breaking Medicine Technology:
Cached News: